Medical Hypotheses
Volume 57, Issue 1 , Pages 76-86 , July 2001

An insight into cortisol and polymyositis control with steroid therapy

  • E.M. Golding

      Affiliations

    • Department of Anesthesiology, Baylor College of Medicine, Houston, Texas, USA
    • ,
  • R.M. Golding

      Affiliations

    • National Unit for Multidisciplinary Studies of Spinal Pain, Townsville General Hospital, Townsville, Queensland, Australia

Received 14 July 2000 ,Accepted 5 January 2001.

References 

    REFERENCES
  1. Thorwald J. Science and secrets of early medicine. UK: Thames and Hudson Ltd,. 1962;
  2. Brophy T, Chalk JB, Ridgeway K, Tyrer JH, Eadie MJ. Cortisol production during high dose dexamethasone therapy in neurological and neurosurgical patients. J Neurol Neurosurg Psychiatry. 1984;47:1081–1086
  3. Villalba L, Adams EM. Update on therapy for refractory dermatomyositis and polymyositis. Curr Opin Rheumatol. 1996;8:544–551
  4. Lundberg I, Chung Y. Treatment and investigation of idiopathic inflammatory myopathies. Rheumatology. 2000;39:7–17
  5. Maegaki Y, Ogura K, Maeoka Y, Takeshita K. Normalization of creatine kinase level during arthritis in a patient with Becker muscular dystrophy. Neurology. 1999;52:172–174
  6. Golding EM, Golding RM. Interpretation of31P MRS spectra in determining intracellular free magnesium and potassium ion concentrations. Magn Reson Med. 1995;33:467–474
  7. Oddis CV. Therapy of inflammatory myopathy. Rheum Dis Clin North Am. 1994;20:899–918

PII: S0306-9877(01)91308-8

doi: 10.1054/mehy.2001.1308

Medical Hypotheses
Volume 57, Issue 1 , Pages 76-86 , July 2001

Article Tools